


GNOMX Revenue
Medical and Diagnostic Laboratories • Manhattan, New York, United States • 1-10 Employees
GNOMX revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical and Diagnostic Laboratories industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at GNOMX
Mark Junewicz
Founder, CEO and Board Member
Company overview
| Headquarters | Manhattan, New York, United States |
| Website | |
| NAICS | 6215 |
| Founded | 2022 |
| Employees | 1-10 |
About GNOMX
GNOMX was founded to commercialize host response epigenetic diagnostics based on research funded by a $46 million DARPA ECHO contract to an academic consortium led by the Icahn School of Medicine at Mount Sinai, Yale University School of Medicine, Princeton University, and the University of Pittsburgh School of Medicine. The DARPA-sponsored research developed patent-pending, beyond state-of-the-art blood epigenetic tests that rapidly diagnose, determine time of exposure, and monitor long-term effect of infections and other exposures.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
GNOMX has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
GNOMX has never raised funding before.
GNOMX Tech Stack
Discover the technologies and tools that power GNOMX's digital infrastructure, from frameworks to analytics platforms.
Hosting
CMS
Miscellaneous
Security
JavaScript frameworks
JavaScript frameworks
Miscellaneous
Frequently asked questions
4.8
40,000 users



